GlassScriptPhysician profile
Lauren E Juneja
NPI 1205192804
$13,592.90
in general payments reported to CMS, 2019-2025
78 companies · $1,350 in 2025
The $1,350 reported for 2025 was more than what a typical Hematology & Oncology provider received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,385 · 2020: $903 · 2021: $1,146 · 2022: $3,325 · 2023: $2,419 · 2024: $2,065 · 2025: $1,350.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,834.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,833.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $1,000.11 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $978.14 | 2019-2025 | Imfinzi, Enhertu, Calquence |
| Novartis Pharmaceuticals Corporation | $813.39 | 2019-2025 | |
| Celgene Corporation | $757.86 | 2019-2025 | Reblozyl, Pomalyst, Opdualag |
| Merck Sharp & Dohme LLC | $732.25 | 2019-2025 | Keytruda, Reblozyl |
| Daiichi Sankyo INC. | $617.21 | 2019-2025 | Enhertu, Injectafer |
| Amgen INC. | $566.90 | 2019-2023 | Blincyto, Kyprolis, Lumakras |
| Eisai INC. | $493.72 | 2019-2025 | |
| Janssen Biotech, INC. | $447.15 | 2019-2025 | Tecvayli, Balversa, Erleada |
| E.R. Squibb & Sons, L.L.C. | $378.04 | 2019-2025 | Opdivo |
| Genentech USA, INC. | $324.09 | 2019-2025 | Polivy, Tecentriq, Tecentriq Hybreza |
| Bayer Healthcare Pharmaceuticals INC. | $316.62 | 2019-2025 | |
| Genzyme Corporation | $316.43 | 2019-2024 | |
| Gilead Sciences, INC. | $308.39 | 2019-2025 | Trodelvy |
| Pharmacyclics LLC, An Abbvie Company | $299.36 | 2019-2023 | Imbruvica |
Show all 78 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ipsen Biopharmaceuticals, INC | $288.94 | 2019-2024 | Somatuline Depot, Onivyde, Tazverik |
| Abbvie INC. | $281.93 | 2019-2025 | |
| Seagen INC. | $231.86 | 2019-2023 | Adcetris, Tukysa |
| Alexion Pharmaceuticals, INC. | $223.17 | 2019-2024 | Ultomiris |
| Incyte Corporation | $211.62 | 2019-2024 | Monjuvi, Jakafi |
| Aveo Pharmaceuticals, INC. | $197.22 | 2022-2024 | Fotivda |
| Lilly USA, LLC | $181.09 | 2019-2024 | Verzenio, Jaypirca, Retevmo |
| Beigene USA, INC. | $172.26 | 2021-2024 | Brukinsa |
| Medtronic, INC. | $169.58 | 2022-2024 | Osteocool Rf Ablation System |
| Glaxosmithkline, LLC. | $159.32 | 2020-2025 | Ojjaara, Blenrep, Jemperli |
| Pharmaessentia USA Corporation | $155.56 | 2023-2025 | Besremi |
| Astellas Pharma US INC | $143.94 | 2019-2025 | Xtandi |
| Jazz Pharmaceuticals INC. | $135.65 | 2022-2025 | |
| Exelixis INC. | $129.43 | 2019-2024 | Cabometyx |
| Blue Earth Diagnostics | $121.83 | 2019 | |
| Emd Serono, INC. | $116.11 | 2019-2024 | Bavencio |
| Regeneron Healthcare Solutions, INC. | $115.99 | 2019-2025 | Libtayo |
| Takeda Pharmaceuticals U.S.A., INC. | $111.69 | 2019-2025 | Ninlaro |
| Array Biopharma INC | $107.89 | 2019-2025 | Mektovi, Lorbrena, Braftovi |
| Blueprint Medicines Corporation | $99.24 | 2020-2025 | Ayvakit |
| Veracyte, INC. | $95.97 | 2021-2023 | |
| Myriad Genetic Laboratories, INC. | $89.13 | 2020-2023 | Myrisk |
| Puma Biotechnology, INC. | $88.82 | 2019-2022 | |
| Recordati_rare_diseases_inc. | $83.04 | 2023-2025 | Sylvant |
| Stemline Therapeutics INC. | $82.47 | 2023-2024 | Orserdu |
| Tempus Ai, INC | $81.83 | 2024 | |
| Adaptive Biotechnologies Corporation | $77.35 | 2023 | Clonoseq |
| Sirtex Medical INC | $77.30 | 2019-2022 | |
| Agios Pharmaceuticals, INC. | $74.99 | 2019-2023 | Pyrukynd |
| Deciphera Pharmaceuticals INC. | $67.23 | 2022-2023 | Qinlock |
| Kite Pharma, INC. | $60.61 | 2020-2025 | Yescarta |
| Tersera Therapeutics LLC | $60.22 | 2024-2025 | Zoladex |
| Tesaro, INC. | $56.18 | 2019 | |
| Apellis Pharmaceuticals, INC. | $55.26 | 2023-2024 | Empaveli |
| Teva Pharmaceuticals USA, INC. | $52.72 | 2019-2020 | |
| Karyopharm Therapeutics INC. | $49.99 | 2020-2023 | Xpovio |
| Adc Therapeutics America, INC. | $49.73 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $47.82 | 2019-2022 | |
| Kyowa Kirin, INC. | $45.95 | 2019 | |
| Rigel Pharmaceuticals, INC. | $43.55 | 2022-2024 | Tavalisse, Rezlidhia |
| Beone Medicines USA, INC. | $40.47 | 2025 | Brukinsa |
| Sobi, INC | $37.44 | 2022-2023 | |
| Taiho Oncology, INC. | $35.78 | 2024 | |
| Springworks Therapeutics, INC. | $35.57 | 2024 | Ogsiveo |
| G1 Therapeutics, INC. | $35.27 | 2022 | |
| Cti Biopharma Corp. | $35.04 | 2022-2023 | Vonjo |
| Genmab U.S., INC. | $34.51 | 2022-2023 | Tivdak |
| Morphosys, US INC. | $30.86 | 2021-2022 | |
| Geron Corporation | $25.32 | 2025 | Rytelo |
| Dendreon Pharmaceuticals LLC | $23.66 | 2020 | |
| Advanced Accelerator Applications | $21.96 | 2020 | |
| Azurity Pharmaceuticals, INC. | $19.56 | 2025 | Danziten |
| Tactile Systems Technology INC | $19.34 | 2021 | |
| Medtronic USA, INC. | $17.68 | 2019 | |
| Servier Pharmaceuticals LLC | $17.11 | 2024 | |
| Mylan Institutional INC. | $16.95 | 2019 | |
| Partner Therapeutics, INC. | $15.94 | 2019 | |
| Clovis Oncology, INC. | $15.41 | 2020 | |
| Mirati Therapeutics, INC. | $15.28 | 2024 | Krazati |
| Pharmacosmos Therapeutics INC. | $14.62 | 2023 | Monoferric |
| Janssen Pharmaceuticals, INC | $14.00 | 2019 | |
| Lexicon Pharmaceuticals, INC. | $13.62 | 2019 | |
| Spectrum Pharmaceuticals INC. | $13.37 | 2023 | Rolvedon |
Drugs and devices associated with these payments
Reblozyl $329Ibrance $327Enhertu $309Tukysa $293Lenvima $185Brukinsa $164Besremi $156Osteocool Rf Ablation System $150Keytruda $145Venclexta $140Tecvayli $139Imfinzi $138Xtandi $131Opdivo $120Fotivda $113Scemblix $102Monjuvi $85.73Stivarga $84.79Vitrakvi $84.79Sylvant $83.04Orserdu $82.47Injectafer $81.26Lorbrena $80.09Mektovi $80.09Braftovi $80.09Clonoseq $77.35Nubeqa $76.47Kisqali $73.05Ayvakit $69.00Trodelvy $68.99Adcetris $65.75Talzenna $65.73Calquence $64.42Orgovyx $63.99Epkinly $62.56Polivy $60.78Zoladex $60.22Tecentriq $58.62Ojjaara $58.19Empaveli $55.26Cabometyx $53.61Imbruvica $52.53Libtayo $50.43Pluvicto $49.55Pomalyst $49.44Elrexfio $45.75Fabhalta $41.03Erleada $40.64Balversa $40.64Talvey $40.40Sarclisa $39.44Tasigna $37.65Yescarta $36.71Comirnaty $36.64Lonsurf $35.78Inqovi $35.78Ogsiveo $35.57Paxlovid $35.54Jevtana $35.27Mekinist $34.91Verzenio $34.53Inlyta $34.35Ziihera $33.75Xyntha $33.31Hympavzi $33.31Benefix $33.31Beqvez $33.31Jakafi $31.32Onivyde $31.29Somatuline Depot $31.29Lutathera $30.81Lynparza $30.77Opdualag $29.86Qinlock $28.23Alecensa $27.40Tecentriq Hybreza $27.40Ninlaro $26.81Zepzelca $26.67Blincyto $25.49Kyprolis $25.49Rytelo $25.32Rezlidhia $24.73Tavalisse $24.73Elahere $21.94Carvykti $21.32Blenrep $21.31Myrisk $21.19Tivdak $20.81Xofigo $20.79Pyrukynd $20.43Danziten $19.56Cablivi $19.06Doptelet $19.00Zejula $18.91Jemperli $18.91Jaypirca $18.62Lumakras $18.51Vectibix $18.23Nplate $18.23Xgeva $18.23
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lauren Juneja listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.